Upload
bathsheba-patterson
View
215
Download
0
Embed Size (px)
Citation preview
Why fixed-dose combinations in hypertension?
Barrios V, Escobar C. Integrated Blood pressure Control. 2010:3 11-19.
Combination therapy is needed when monotherapy does not attain blood pressure objectives and as a first-line treatment in high-risk patients.
2007 and 2009 updates of European hypertension guidelines
Advantages of a fixed-dose combination:Increased antihypertensive efficacy+ lower incidence of adverse events
+ improved compliance
ACE inihibitor + diuretic combination is very beneficial throughout the cardiovascular continuum, as demonstrated by the perindopril/indapamide combination
Superior LVMI reduction with perindopril/indapamide
versus enalapril
Effect of the combination perindopril/indapamide (2 mg/0.625 mg up to 8 mg/2.5 mg)and enalapril (10 mg up to 40 mg/daily) on left ventricular mass index (g/m2).
Data from the PICXEL study.
Barrios V, Escobar C. Integrated Blood pressure Control. 2010:3 11-19.
AER reduction greater with perindopril/indapamide
versus enalapril
Effect of the combination perindopril/indapamide (2 mg/0.625 mg up to 8 mg/2.5 mg)and enalapril (10 mg up to 40 mg/daily) on urinary albumin excretion (% of change from
baseline). Data from the PREMIER study.
Barrios V, Escobar C. Integrated Blood pressure Control. 2010:3 11-19.
1. ADVANCE Collaborative Group. Lancet. 2007;370:829-840. 2. PROGRESS Collaborative Group. Lancet. 2001;358:1033-1041. 3. Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH trial investigators. N Engl J Med. 2008;359:2417-2428. 4. Bakris GL, Sarafi dis PA, Weir MR, et al; ACCOMPLISH Trial investigators. Lancet. 2010;375:1173-1181.
Risk of cardiovascular events reducedin important trials
ADVANCE1
Active group vs control
PROGRESS2
Active group vs control
ACCOMPLISH3,4
Excess risk observed in the hydrochlorothiazide** arm when combined with
an ACE inhibitor
**HCTZ+ benazepril versus amlodipine + benazepril
Indapamide differs from thiazide diuretics
Indapamide Hydrochlorothiazide
Metabolically neutral1,2 Increases risk of diabetes8
Protects against stroke3-5
Protects the heart3-6
Reduces microalbuminuria7
Reduces total mortality3-5
1. Ambrosioni E, Safar M, Degautec J-P, et al. J Hypertens. 1998;16:1677-1684. 2. Akram J, Sheikh UE, Mahmood M, Donnelly R. Curr Med Res Opin. 2007;23:2929-2936. 3. Messerli FH, MakaniH, Benjo A, Romero J, Alviar C, Bangalore S. J Am Coll Cardiol. 2011;57:590-600. 4. Gaciong Z, Symonides B. Expert Opin Pharmacother. 2010;11:2579-2597. 5. Beckett NS, Peters R, Fletcher AE, et al. N Engl J Med. 2008;358:1887-1898. 6. Gosse P, Sheridan DJ, Zannad F, et al. J Hypertens. 2000;18:1465-1475. 7. Marre M, Garcia J, Kokot F, et al. J Hypertens. 2004;22:1613-1622. 8. Pepine CJ, Handberg EM, Cooper-DeHoff R, et al. JAMA. 2003;290:2805-2816.